Dr. Scott Alfred Fretzin
Claim this profileDawes Fretzin Clinical Research Group, LLC
Studies Atopic Dermatitis
Studies Eczema
3 reported clinical trials
2 drugs studied
Affiliated Hospitals
More about Scott Alfred Fretzin
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Scott Alfred Fretzin has experience with
- Lebrikizumab
- Mirikizumab
Breakdown of trials Scott Alfred Fretzin has run
Atopic Dermatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Alfred Fretzin specialize in?
Scott Alfred Fretzin focuses on Atopic Dermatitis and Eczema. In particular, much of their work with Atopic Dermatitis has involved treating patients, or patients who are undergoing treatment.
Is Scott Alfred Fretzin currently recruiting for clinical trials?
No, Scott Alfred Fretzin is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Scott Alfred Fretzin has studied deeply?
Yes, Scott Alfred Fretzin has studied treatments such as Lebrikizumab, Mirikizumab.
What is the best way to schedule an appointment with Scott Alfred Fretzin?
Apply for one of the trials that Scott Alfred Fretzin is conducting.
What is the office address of Scott Alfred Fretzin?
The office of Scott Alfred Fretzin is located at: Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana 46250 United States. This is the address for their practice at the Dawes Fretzin Clinical Research Group, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.